A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4%

NCT00151541 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Dapsone Topical Gel + adapalene gel 0.1%
DRUG: Dapsone Topical Gel + benzoyl peroxide gel 4%
DRUG: Dapsone Topical Gel + vehicle control

Sponsor

Allergan